Bose, M.; Yergeau, C.; D’Souza, Y.; Cuthbertson, D.D.; Lopez, M.J.; Smolen, A.K.; Braverman, N.E.
Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review. Cells 2022, 11, 1891.
https://doi.org/10.3390/cells11121891
AMA Style
Bose M, Yergeau C, D’Souza Y, Cuthbertson DD, Lopez MJ, Smolen AK, Braverman NE.
Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review. Cells. 2022; 11(12):1891.
https://doi.org/10.3390/cells11121891
Chicago/Turabian Style
Bose, Mousumi, Christine Yergeau, Yasmin D’Souza, David D. Cuthbertson, Melisa J. Lopez, Alyssa K. Smolen, and Nancy E. Braverman.
2022. "Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review" Cells 11, no. 12: 1891.
https://doi.org/10.3390/cells11121891
APA Style
Bose, M., Yergeau, C., D’Souza, Y., Cuthbertson, D. D., Lopez, M. J., Smolen, A. K., & Braverman, N. E.
(2022). Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review. Cells, 11(12), 1891.
https://doi.org/10.3390/cells11121891